(c) 2024 PillSync.com

buprenorphine and naloxone 2 mg

1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )

Lannett Company, Inc.


9 hours ago HEXAGON PINK 2 buprenorphine and naloxone 2 mg

HEXAGON PINK 2

9 hours ago HEXAGON PINK 2 buprenorphine and naloxone 2 mg

2 HEXAGON PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

BUPRENORPHINE AND NALOXONE sublingual tablets, USP are a hexagonal light pink tablet, debossed with a numeric imprint on one side identifying the strength, supplied in white HDPE bottles: NDC 62175-452-32 (buprenorphine 2 mg and naloxone 0.5 mg/sublingual tablet; content expressed in terms of free base) debossed with a 2 on one side - 30 tablets per bottle NDC 62175-458-32 (buprenorphine 8 mg and naloxone 2 mg/sublingual tablet; content expressed in terms of free base) debossed with an 8 on one side - 30 tablets per bottle Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Store

BUPRENORPHINE AND NALOXONE sublingual tablets securely and dispose of properly [see Patient Counseling Information ( 17 )] .


More pills like HEXAGON 2












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site